PL1924270T3 - Kompleksowe związki żelaza (III) do doustnego leczenia stanów niedoboru żelaza u pacjentów z przewlekle zapalnym schorzeniem jelit - Google Patents
Kompleksowe związki żelaza (III) do doustnego leczenia stanów niedoboru żelaza u pacjentów z przewlekle zapalnym schorzeniem jelitInfo
- Publication number
- PL1924270T3 PL1924270T3 PL06778319T PL06778319T PL1924270T3 PL 1924270 T3 PL1924270 T3 PL 1924270T3 PL 06778319 T PL06778319 T PL 06778319T PL 06778319 T PL06778319 T PL 06778319T PL 1924270 T3 PL1924270 T3 PL 1924270T3
- Authority
- PL
- Poland
- Prior art keywords
- iron
- iii
- chronic inflammatory
- patients
- intestinal diseases
- Prior art date
Links
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 title abstract 2
- 206010022971 Iron Deficiencies Diseases 0.000 title abstract 2
- 230000001684 chronic effect Effects 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 230000002757 inflammatory effect Effects 0.000 title abstract 2
- 208000028774 intestinal disease Diseases 0.000 title abstract 2
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000000767 anti-ulcer Effects 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05107790A EP1757299A1 (de) | 2005-08-25 | 2005-08-25 | Eisen(III)-Komplexverbindungen zur Behandlung von Eisenmangel-Zuständen bei Patienten mit chronisch-entzündlicher Darmerkrankung |
| EP06778319A EP1924270B1 (de) | 2005-08-25 | 2006-08-22 | Eisen(iii) komplex-verbindungen zur oralen behandlung von eisenmangel bei patienten mit chronischen entzündlichen darmerkrankungen |
| PCT/EP2006/065532 WO2007023154A2 (de) | 2005-08-25 | 2006-08-22 | EISEN(III)-KOMPLEXVERBINDtMGEN ZUR BEHANDLUNG VON EISENMANGEL-ZUSTÄNDEN BEI PATIENTEN MIT CHRONISCH-ENTZÜNDLICHER DARMERKRANKUNG |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1924270T3 true PL1924270T3 (pl) | 2010-08-31 |
Family
ID=35504893
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06778319T PL1924270T3 (pl) | 2005-08-25 | 2006-08-22 | Kompleksowe związki żelaza (III) do doustnego leczenia stanów niedoboru żelaza u pacjentów z przewlekle zapalnym schorzeniem jelit |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20080234226A1 (pl) |
| EP (2) | EP1757299A1 (pl) |
| JP (1) | JP4997241B2 (pl) |
| KR (1) | KR101051171B1 (pl) |
| CN (1) | CN101247813A (pl) |
| AT (1) | ATE460940T1 (pl) |
| AU (1) | AU2006283895B2 (pl) |
| BR (1) | BRPI0614875A2 (pl) |
| CA (1) | CA2617510C (pl) |
| DE (1) | DE502006006466D1 (pl) |
| DK (1) | DK1924270T3 (pl) |
| ES (1) | ES2343585T3 (pl) |
| MX (1) | MX2008002558A (pl) |
| PL (1) | PL1924270T3 (pl) |
| PT (1) | PT1924270E (pl) |
| RU (1) | RU2411037C2 (pl) |
| WO (1) | WO2007023154A2 (pl) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10249552A1 (de) | 2002-10-23 | 2004-05-13 | Vifor (International) Ag | Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel |
| WO2007081744A2 (en) * | 2006-01-06 | 2007-07-19 | Luitpold Pharmaceuticals, Inc. | Methods and compositions for administration of iron |
| EP1997833A1 (de) | 2007-05-29 | 2008-12-03 | Vifor (International) Ag | Wasserlösliche Eisen-Kohlenhydratderivat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel |
| TWI592159B (zh) | 2007-11-16 | 2017-07-21 | 威佛（國際）股份有限公司 | 藥學組成物 |
| US20090307082A1 (en) * | 2008-06-06 | 2009-12-10 | Meebo Inc. | System and method for web advertisement |
| SI2411053T1 (sl) | 2009-03-25 | 2017-04-26 | Pharmacosmos Holding A/S | Stabilna spojina železovega oligosaharida |
| DE102010023850B4 (de) * | 2010-05-15 | 2013-12-19 | Johannes-Gutenberg-Universität Mainz | Funktionalisierte Nanopartikel mit verbesserter Bioverfügbarkeit |
| WO2012104204A1 (en) | 2011-01-31 | 2012-08-09 | Vifor (International) Ag | Iron-carbohydrate complex compounds for the intravenous therapy of malaria |
| AU2013201308B2 (en) | 2011-10-13 | 2015-01-29 | Alebund Pharmaceuticals (Hong Kong) Limited | Iron-fiber composition, preparation and uses thereof |
| CN109497565B (zh) | 2013-03-08 | 2021-10-26 | 上海礼邦医药科技有限公司 | 金属离子-功能性纤维组分络合物组合物、其制备及用途 |
| WO2015101971A1 (en) | 2014-01-06 | 2015-07-09 | Iron Therapeutics Holdings Ag | Dosage regimen of ferric trimaltol |
| GB201418710D0 (en) | 2014-10-21 | 2014-12-03 | Iron Therapeutics Holdings Ag | Dosage regimen |
| CN111257568A (zh) * | 2020-02-24 | 2020-06-09 | 中国科学院昆明动物研究所 | 检测转铁蛋白表达量的试剂在制备肠道免疫耐受失衡疾病诊断试剂或试剂盒中的应用 |
| CN114028423B (zh) * | 2021-12-13 | 2023-05-23 | 广东粤港澳大湾区国家纳米科技创新研究院 | 修饰的纳米氧化铁在制备预防和/或治疗炎性肠病的药物中的应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1467980C3 (de) | 1960-03-16 | 1975-04-30 | Laboratorien Hausmann Ag, St. Gallen (Schweiz) | Verfahren zur Herstellung von injizierbaren, haltbaren Eisen(lll)-hydroxyd-Polymaltose-Komplexen und diese enthaltende pharmazeutische Präparate |
| US3076798A (en) | 1961-02-23 | 1963-02-05 | Hausmann Lab Ltd | Process for preparing a ferric hydroxide polymaltose complex |
| US3766165A (en) | 1966-08-17 | 1973-10-16 | Pfizer | Polysaccharides and their preparation |
| DE4421159C1 (de) | 1994-06-20 | 1995-08-24 | Thomas Bruns | Verwendung von Eisen(III)-oxid (Fe¶2¶O¶3¶) bei Immunschwäche |
| US5756715A (en) * | 1996-11-08 | 1998-05-26 | Abbott Laboratories | Process for making crystalline iron dextran |
| DK172860B1 (da) | 1998-03-25 | 1999-08-16 | Pharmacosmos Holding As | Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman |
| IT1301728B1 (it) * | 1998-06-16 | 2000-07-07 | Therapicon Srl | Preparazione di un complesso antianemico. |
| WO2002046241A2 (en) | 2000-12-07 | 2002-06-13 | Ad 'zdravlje' Farmaceutsko - Hemijska Industrija, Centar Za Istrazivanje I Razvoj | Polynuclear complex fe(iii) with pullulan oligomers, process of its obtaining, and pharmaceutical preparations on the basis of the complex |
| US6821547B2 (en) | 2001-04-10 | 2004-11-23 | Danisco Usa, Inc. | Polymerization of mono and disaccharides with monocarboxylic acids and lactones |
| DE60307249T2 (de) | 2002-04-09 | 2007-03-15 | Pharmacosmos Holding A/S | Eisen-dextrin verbindung zur behandlung von anämien durch eisenmangel |
| DE10249552A1 (de) * | 2002-10-23 | 2004-05-13 | Vifor (International) Ag | Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel |
| JP2004250383A (ja) * | 2003-02-20 | 2004-09-09 | Fujisawa Pharmaceut Co Ltd | 鉄分補給用組成物 |
-
2005
- 2005-08-25 EP EP05107790A patent/EP1757299A1/de not_active Withdrawn
-
2006
- 2006-08-22 US US12/064,053 patent/US20080234226A1/en not_active Abandoned
- 2006-08-22 CN CNA2006800305747A patent/CN101247813A/zh active Pending
- 2006-08-22 ES ES06778319T patent/ES2343585T3/es active Active
- 2006-08-22 BR BRPI0614875-1A patent/BRPI0614875A2/pt not_active IP Right Cessation
- 2006-08-22 RU RU2008111148/15A patent/RU2411037C2/ru not_active IP Right Cessation
- 2006-08-22 AU AU2006283895A patent/AU2006283895B2/en not_active Ceased
- 2006-08-22 PT PT06778319T patent/PT1924270E/pt unknown
- 2006-08-22 PL PL06778319T patent/PL1924270T3/pl unknown
- 2006-08-22 JP JP2008527459A patent/JP4997241B2/ja not_active Expired - Fee Related
- 2006-08-22 MX MX2008002558A patent/MX2008002558A/es active IP Right Grant
- 2006-08-22 DE DE502006006466T patent/DE502006006466D1/de active Active
- 2006-08-22 DK DK06778319.1T patent/DK1924270T3/da active
- 2006-08-22 WO PCT/EP2006/065532 patent/WO2007023154A2/de active Application Filing
- 2006-08-22 AT AT06778319T patent/ATE460940T1/de active
- 2006-08-22 KR KR1020087006998A patent/KR101051171B1/ko not_active IP Right Cessation
- 2006-08-22 CA CA2617510A patent/CA2617510C/en not_active Expired - Fee Related
- 2006-08-22 EP EP06778319A patent/EP1924270B1/de not_active Not-in-force
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007023154A2 (de) | 2007-03-01 |
| KR20080038432A (ko) | 2008-05-06 |
| CA2617510A1 (en) | 2007-03-01 |
| RU2008111148A (ru) | 2009-09-27 |
| JP4997241B2 (ja) | 2012-08-08 |
| DE502006006466D1 (de) | 2010-04-29 |
| MX2008002558A (es) | 2008-03-14 |
| EP1924270A2 (de) | 2008-05-28 |
| DK1924270T3 (da) | 2010-07-19 |
| US20080234226A1 (en) | 2008-09-25 |
| EP1757299A1 (de) | 2007-02-28 |
| CN101247813A (zh) | 2008-08-20 |
| AU2006283895B2 (en) | 2011-06-16 |
| ES2343585T3 (es) | 2010-08-04 |
| AU2006283895A1 (en) | 2007-03-01 |
| JP2009506011A (ja) | 2009-02-12 |
| KR101051171B1 (ko) | 2011-07-22 |
| ATE460940T1 (de) | 2010-04-15 |
| RU2411037C2 (ru) | 2011-02-10 |
| CA2617510C (en) | 2013-01-08 |
| EP1924270B1 (de) | 2010-03-17 |
| WO2007023154A3 (de) | 2007-05-18 |
| BRPI0614875A2 (pt) | 2011-04-19 |
| PT1924270E (pt) | 2010-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL1924270T3 (pl) | Kompleksowe związki żelaza (III) do doustnego leczenia stanów niedoboru żelaza u pacjentów z przewlekle zapalnym schorzeniem jelit | |
| UA88647C2 (ru) | C-арилгликозидные ингибиторы sglt2 и процесс лечения с их использованием | |
| NO20074999L (no) | Metode og preparat for behandling av perifere vaskulaere sykdommer | |
| EP1962839A4 (en) | ADMINISTRATION OF A MNTOR INHIBITOR FOR THE TREATMENT OF PATIENTS WITH CANCER | |
| WO2009050506A3 (en) | Combination 059 | |
| WO2006078463A3 (en) | Method for treating cardiovascular disease | |
| MX2007000304A (es) | Metodo de tratamiento de enfermedad de almacenamiento de glucogeno o polisacaridos. | |
| HK1120441A1 (en) | Drugs for treatment of ovarian cancer | |
| EA201100266A1 (ru) | Диокса-бицикло[3.2.1]октан-2,3,4-триольные производные | |
| IL194948A0 (en) | 2-pyridone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial | |
| WO2007101232A3 (en) | Inhibition of jak2 as a treatment of pulmonary arterial hypertension | |
| NO20073854L (no) | Doseringsform og fremgangsmate for vedvarende frigjoring av en substituert pyrazinforbindelse | |
| UA96304C2 (en) | 2-METHYLMORPHOLINE PYRIDO-, PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS | |
| WO2007072221A3 (en) | Surface marker-directed cancer therapeutics | |
| UA96969C2 (en) | Acylaminopyrazoles as fgfr inhibitors | |
| TW200724146A (en) | Use of LGG in the manufacture of a medicament for the treatment, prevention or reduction of systemic inflammation in a formula-fed infant | |
| EP1843781A4 (en) | COMPOSITION FOR THE PREVENTION, TREATMENT AND DIAGNOSIS OF INFLAMMATORY CHRONIC DISEASES OF AIRWAYS | |
| MX2007003790A (es) | Metodo de tratamiento. | |
| EA200702026A1 (ru) | Лечение или предупреждение зуда | |
| CY1108501T1 (el) | Συνθεση δια την προληψη και θεραπευτικη αγωγη ασθενειων κρυολογηματος | |
| NO20070250L (no) | S-Tenatoprazol-natriummonohydratsalt og dennes anvendelse i form av en protonpumpe-inhibitor | |
| WO2007092436A3 (en) | Compounds for treating inflammatory disorders, demyelinating disorders and cancers | |
| MX2010007527A (es) | Composicion farmaceutica, uso del derivado 2-iminopirrolidina para la produccion de la composicion farmaceutica y kit para el tratamiento o mejora de enfermedaes cardiacas. | |
| EP1495755B8 (fr) | Utilisation de la citrulline dans la fabrication d'un médicament pour le traitement de l'insuffisance intestinale liée au vieillissement ou à une irradiation | |
| MX2007011544A (es) | Uso de macrolidas para tratamiento de inflamacion intestinal. |